Evidence map›Paper›PMID 27608031›Full record

SynthesisInternational journal of environmental research and public health2016

Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.

Shu-Xia Guo, Ming-Hong Yao, Yu-Song Ding, Jing-Yu Zhang, Yi-Zhong Yan, Jia-Ming Liu, Mei Zhang, Dong-Sheng Rui, Qiang Niu, Jia He and 2 more

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in International journal of environmental research and public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Cholesterol Ester Transfer ProteinIranian journal of medical sciences · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Association of RS708272 (Biomolecules · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Shu-Xia GuoDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. pge888@sina.com.
Ming-Hong YaoDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. ymhldjxa@sina.com.
Yu-Song DingDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. 13399931625@163.com.
Jing-Yu ZhangDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. yfyxxzjy@126.com.
Yi-Zhong YanDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. erniu19880215@sina.com.
Jia-Ming LiuDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. liujiaming@shzu.edu.cn.
Mei ZhangDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. zmberry@foxmail.com.
Dong-Sheng RuiDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. ruidongsheng@gmail.com.
Qiang NiuDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. niuqiang1214@163.com.
Jia HeDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. hejia123.shihezi@163.com.
Heng GuoDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. guoheng@shzu.edu.cn.
Ru-Lin MaDepartment of Preventive Medicine, Shihezi University School of Medicine, Shihezi 832000, Xinjiang Uyghur Autonomous Region, China. shzmrl@sina.com.
Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have evaluated the associations between the cholesteryl ester transfer protein (CETP) TaqIB polymorphism (rs708272), the risk of developing composite ischemic cardiovascular disease (CVD) and the concentration of high-density lipoprotein cholesterol (HDL-C), but results remain controversial. The objective of this study was to investigate whether a relationship exists between these factors.

methodsWe conducted a meta-analysis of available studies to clarify the associations of the CETP TaqIB polymorphism with HDL-C concentration and the composite ischemic CVD risk in both Asians and Caucasians. All statistical analyses were done with Stata 12.0.

resultsThrough utilization of the Cochrane Library, Embase, PubMed, Web of Science, Springer, China Science and Technology Journal Database, China National Knowledge Infrastructure, Google Scholar, and Baidu Library, a total of 45 studies from 44 papers with 20,866 cases and 21,298 controls were combined showing a significant association between the CETP TaqIB variant and composite ischemic CVD risk. Carriers of allele TaqIB-B1 were found to have a higher risk of composite ischemic CVD than non-carriers: OR = 1.15, 95% CI = 1.09-1.21, p < 0.001. Meanwhile, 28 studies with 23,959 subjects were included in the association between the CETP TaqIB polymorphism and the concentration of HDL-C. RESULTS suggested that carriers of the B1B1 genotype had lower concentrations of HDL-C than those of the B2B2 genotype: SMD = 0.50, 95% CI = 0.36-0.65, p < 0.001.

conclusionsThe synthesis of available evidence demonstrates that the CETP TaqIB polymorphism protects against composite ischemic CVD risk and is associated with a higher HDL-C concentration in both Asians and Caucasians.

Indexed as

AgedAllelesAsian PeopleChinaCholesterol Ester Transfer ProteinsCholesterol, HDLFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMyocardial IschemiaPolymorphism, GeneticRisk AssessmentWhite PeopleCETP protein, humanCholesterol Ester Transfer ProteinsCholesterol, HDLcholesteryl ester transfer proteincomposite ischemic cardiovascular diseaseHDL-Cmeta-analysispolymorphism

Identifiers

PMID27608031
PMCPMC5036715
OpenAlexW2516846089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.